Overview
Wholesale Trade

COSMO BIO COMPANY,LIMITED

Cosmo Bio is a life science trading company that sources and distributes over 10 million cutting-edge research reagents, instruments, and consumables from approximately 500 suppliers worldwide to researchers at universities, public research institutions, and corporations across Japan. The company also develops and manufactures its own proprietary products—including primary culture cells, assay kits, and custom peptide synthesis and antibody production services—as well as contract research services such as drug discovery support, intestinal flora analysis, and protein production using genome-edited chicken egg bioreactor technology. Its U.S. subsidiary, COSMO BIO USA, INC., handles global export sales of Japanese-manufactured life science products outside Japan.

Market Cap
US$43.9M
¥7.01B
EV
US$2.56M
¥0.41B
StockUS$7.70(¥1,230)▲+0.00%
US$1 = ¥159.70 (2026-11-12)
LTM EV/EBITDA
0.8
x
LTM EV/EBIT
1.3
x
LTM PER
21.2
x
LTM PBR
0.8
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-4.0%pt
100
Nov 13, 25 – Nov 13, 26StockTOPIX
MC → EV Bridge
US$43.9M¥7.01BMarket CapUS$0.14M¥0.02B+ DebtUS$22.4M¥3.58B− CashUS$22.8M¥3.64B− Inv. Sec.US$3.71M¥0.59B+ NCIUS$2.56M¥0.41BEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (US$)
US$57.8M¥9.23B'21/12US$59.8M¥9.55B'22/12US$58.5M¥9.34B'23/12US$62.8M¥10.0B'24/12US$67.4M¥10.8B'25/12
EBITDA 5Y (US$)
US$7.60M¥1.21B'21/12US$5.99M¥0.96B'22/12US$4.18M¥0.67B'23/12US$2.84M¥0.45B'24/12US$3.19M¥0.51B'25/12
Net Income 5Y (US$)
US$4.61M¥0.74B'21/12US$3.24M¥0.52B'22/12US$2.77M¥0.44B'23/12US$1.64M¥0.26B'24/12US$2.11M¥0.34B'25/12
Capital Structure
100%
EquityD/E 0.00xDebt
Liquidity vs Debt 5Y (US$)▲ Net Cash
CashInv. Sec.Debt
US$31.0M¥4.96BUS$0.13M¥0.02B'21/12US$32.4M¥5.17BUS$0.13M¥0.02B'22/12US$35.0M¥5.59BUS$0.13M¥0.02B'23/12US$35.6M¥5.68BUS$0.14M¥0.02B'24/12US$41.1M¥6.56BUS$0.14M¥0.02B'25/12
Shareholders
Top 10 hold 54.2%
1
Tokyo Small and Medium Business Investment & Consultation Co., Ltd.
20.21%
2
みずほ信託銀行株式会社 退職給付信託 コスモ石油口 再信託受託者 株式会社日本カストディ銀行
10.10%
3
UH Partners 2 Investment Limited Partnership
7.69%
4
Hikari Tsushin KK Investment Limited Partnership
6.59%
5
UH Partners 3 Investment Limited Partnership
2.37%
6
Haruhisa SAKURAI
1.68%
7
COSMO BIO COMPANY,LIMITED Employee Stock Ownership Association
1.44%
8
Yumiko SUZUKI
1.44%
9
Kiyoshi TAKAHASHI
1.32%
10
Toshiaki FUNATO
1.32%
Management
7 officers
Norihiko SHIBAYAMA
Representative Director, President
Apr 1994 Joined Maruzen Petrochemical Co., Ltd. Oct 2000 Joined the Company Apr 2012 General Manager, Information Systems Department, the Company Mar 2014 Director, BM Kiki Co., Ltd. Nov 2016 General Manager, General Affairs Department and General Manager, Information Systems Department, the Company Mar 2017 Director, General Manager, General Affairs Department and General Manager, Information Systems Department, the Company Mar 2020 Director, General Manager, General Affairs Department, BM Kiki Co., Ltd.; Managing Director, General Manager, General Affairs Department and General Manager, Information Systems Department, the Company Mar 2022 Representative Director, President, BM Kiki Co., Ltd. (current) Managing Director, General Manager, General Affairs Department, the Company Mar 2023 Senior Managing Director, General Manager, General Affairs Department, the Company Nov 2023 Representative Director, Senior Managing Director, Acting for President, General Manager, General Affairs Department, the Company Mar 2024 Representative Director, President, the Company (current) Apr 2026 Representative Director, President, President Executive Officer, the Company (scheduled)
1969-08-21
Junko TOCHIGI
Managing Director, General Manager, Planning Department
Apr 1998 Joined the Company Apr 2013 General Manager, Product Information Department, the Company Mar 2017 Director, General Manager, Product Information Department, the Company Apr 2017 Director, General Manager, Planning Department, the Company Mar 2021 Director, BM Kiki Co., Ltd. Mar 2022 Representative Director, President, COSMO BIO USA, INC.; Representative Director, Protein Tech Japan Co., Ltd. (current) Mar 2023 Managing Director, General Manager, Planning Department, the Company (current) Nov 2025 Director and Chief Executive Officer, COSMO BIO USA, INC. (current) Apr 2026 Managing Director, Managing Executive Officer, General Manager, Corporate Planning Department, the Company (scheduled)
1973-12-25
Masanori HAYASHI
Director, General Manager, Finance Department
Apr 1999 Joined Kyowa Hakko Kogyo Co., Ltd. (now Kyowa Kirin Co., Ltd.) May 2012 Joined the Company Apr 2019 General Manager, Finance Department, the Company Mar 2020 General Manager, Finance Department, BM Kiki Co., Ltd. Mar 2023 Director, General Manager, Finance Department, the Company (current) Mar 2024 Director, General Manager, Finance Department, BM Kiki Co., Ltd. (current) Apr 2026 Director, Executive Officer, General Manager, Finance Department, the Company (scheduled)
1975-09-08
Kazutoshi SATO
Independent Outside Director (Full-time Audit and Supervisory Committee Member)
Apr 1987 Joined Sumitomo Fudosan Hanbai Co., Ltd. Jan 1993 Joined Cosmo Oil Co., Ltd. Jun 2011 Sapporo Branch Manager, Cosmo Oil Co., Ltd. Jun 2014 Takamatsu Branch Manager, Cosmo Oil Co., Ltd. Oct 2015 Takamatsu Branch Manager, Cosmo Oil Marketing Co., Ltd. Jun 2017 Director, Executive Officer, General Manager, General Affairs Department, Maruzen Petrochemical Co., Ltd. Mar 2020 Director, Maruzen Petrochemical Co., Ltd.; Audit & Supervisory Board Member, BM Kiki Co., Ltd. (current) Outside Audit & Supervisory Board Member, the Company Mar 2022 Outside Director (Audit and Supervisory Committee Member), the Company (current)
1964-01-10
Haruo SASAKI
Independent Outside Director (Audit and Supervisory Committee Member)
Nov 1974 Joined Chuo Kaikei Jimusho Audit Corporation Feb 1990 Established Sasaki Accounting Office; Representative (current) Dec 2000 Outside Audit & Supervisory Board Member, the Company Mar 2022 Outside Director (Audit and Supervisory Committee Member), the Company (current)
1950-12-18
Kazuya SHIMAMURA
Independent Outside Director (Audit and Supervisory Committee Member)
Oct 1995 Joined Tohmatsu LLC (now Deloitte Tohmatsu LLC) Oct 2004 Joined Abe, Ikubo & Katayama Law Office Mar 2008 Established Shimamura Law and Accounting Office; Representative (current) Jun 2008 Outside Audit & Supervisory Board Member, Sodick Plastech Co., Ltd. Jul 2008 Outside Audit & Supervisory Board Member, 3D Matrix, Ltd. Jul 2012 Outside Director, 3D Matrix, Ltd. Mar 2014 Outside Director, the Company Jun 2015 Outside Audit & Supervisory Board Member, IB System Co., Ltd. Jan 2017 Outside Audit & Supervisory Board Member, AZOOM Co., Ltd.; Outside Director, CAICA Co., Ltd. (now CAICA DIGITAL Co., Ltd.) Oct 2019 Outside Director (Audit and Supervisory Committee Member), Meiho Enterprise Co., Ltd. Mar 2022 Outside Director (Audit and Supervisory Committee Member), the Company (current) Dec 2023 Outside Director (Audit and Supervisory Committee Member), AZOOM Co., Ltd. (current)
1972-10-20
Junichiro HARAGUCHI
Independent Outside Director (Audit and Supervisory Committee Member)
Apr 1984 Joined Tokyo Small and Medium Enterprise Investment and Development Corporation Jun 2004 Director, Finance Office, Tokyo Small and Medium Enterprise Investment and Development Corporation Jul 2005 Director, Secretariat Office, Tokyo Small and Medium Enterprise Investment and Development Corporation Apr 2007 Manager, Human Resources Department, Tokyo Small and Medium Enterprise Investment and Development Corporation Apr 2011 Director, Business Department No. 5, Tokyo Small and Medium Enterprise Investment and Development Corporation Apr 2016 Director, Business Department No. 2, Tokyo Small and Medium Enterprise Investment and Development Corporation Apr 2017 Senior Counselor and Acting Chief Examiner, Tokyo Small and Medium Enterprise Investment and Development Corporation Jun 2017 Outside Audit & Supervisory Board Member, Kimoto Co., Ltd. (current) Oct 2020 Special Senior Counselor and Acting Chief Examiner, Tokyo Small and Medium Enterprise Investment and Development Corporation Apr 2021 Special Senior Counselor, Business Department No. 5 and Sales Division, Tokyo Small and Medium Enterprise Investment and Development Corporation Apr 2023 Special Senior Counselor, Business Department No. 5 and Business General Division, Tokyo Small and Medium Enterprise Investment and Development Corporation (current) Mar 2024 Outside Director (Audit and Supervisory Committee Member), the Company (current)
1960-09-30
Large Shareholding Reports
UH Partners 2 Co.,Ltd.
2026-11-13
7.25%→7.25%
UH Partners 2 Co., Ltd.
2025-11-18
7.25%→7.25%
UH Partners 2
2025-09-26
7.11%→7.25%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-11-13
Large Shareholding Report
TDnet
2026-11-06
Q3 Earnings Flash
FY ending Dec 2026
EDINET
2026-08-07
Semi-Annual Securities Report
Period: Jan 2026 – Dec 2026
TDnet
2026-08-05
Q2 Earnings Flash
FY ending Dec 2026
TDnet
2026-07-24
業績予想の修正
TDnet
2026-05-08
Q1 Earnings Flash
FY ending Dec 2026
EDINET
2026-03-18
Annual Securities Report
Period: Jan 2025 – Dec 2025
TDnet
2026-02-13
Full-Year Earnings Flash
FY ending Dec 2025
EDINET
2025-11-18
Large Shareholding Report
TDnet
2025-11-07
Q3 Earnings Flash
FY ending Dec 2025
EDINET
2025-09-26
Large Shareholding Report
EDINET
2025-08-08
Semi-Annual Securities Report
Period: Jan 2025 – Dec 2025
TDnet
2025-05-09
Q1 Earnings Flash
FY ending Dec 2025
EDINET
2025-03-26
Annual Securities Report
Period: Jan 2024 – Dec 2024
EDINET
2024-08-09
Semi-Annual Securities Report
Period: Jan 2024 – Dec 2024
EDINET
2024-05-13
Quarterly Securities Report
Period: Jan 2024 – Mar 2024
EDINET
2024-03-27
Annual Securities Report
Period: Jan 2023 – Dec 2023
EDINET
2023-11-10
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-10
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-05-12
Quarterly Securities Report
Period: Jan 2023 – Mar 2023
EDINET
2023-03-24
Annual Securities Report
Period: Jan 2022 – Dec 2022
EDINET
2022-11-10
Quarterly Securities Report
EDINET
2022-08-12
Quarterly Securities Report
EDINET
2022-05-12
Quarterly Securities Report
EDINET
2022-03-24
Annual Securities Report
EDINET
2021-11-10
Quarterly Securities Report
EDINET
2021-08-11
Quarterly Securities Report
EDINET
2021-05-12
Quarterly Securities Report
EDINET
2021-03-24
Annual Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
Ask me!
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →